{"rows":[{"id":5087,"title":"Psilocybin: the magic medicine for depression?","authors":"Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft","journal":"BJPsych Open","publication_date":"2021-06-01","publication_year":2021,"doi":"10.1192/bjo.2021.456","pubmed_id":null,"openalex_id":"https://openalex.org/W3173209673","source_url":"https://doi.org/10.1192/bjo.2021.456","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:45","bibtex":null,"source_record_id":"DOI:10.1192/bjo.2021.456","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1192/bjo.2021.456","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1192/bjo.2021.456","source_url":"https://doi.org/10.1192/bjo.2021.456","doi":"10.1192/bjo.2021.456","pmid":"","publication_date":"2021-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4004,"title":"From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry","authors":"Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal","journal":"BJPsych Open","publication_date":"2026-06-01","publication_year":2026,"doi":"10.1192/bjo.2026.11141","pubmed_id":null,"openalex_id":"https://openalex.org/W7166698621","source_url":"https://doi.org/10.1192/bjo.2026.11141","substance_tags":"psilocybin","topic_tags":"Addiction,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:35","last_checked":"2026-08-09 08:25:07","bibtex":null,"source_record_id":"DOI:10.1192/bjo.2026.11141","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1192/bjo.2026.11141","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1192/bjo.2026.11141","source_url":"https://doi.org/10.1192/bjo.2026.11141","doi":"10.1192/bjo.2026.11141","pmid":"","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":927,"title":"Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: Case report and thematic analysis of one participant's experience","authors":"Wahba M, Hayes C, Kletter M, McAllister-Williams RH","journal":"BJPsych Open","publication_date":"2024-10-31","publication_year":2024,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W7139416359","source_url":"https://openalex.org/W7139416359","substance_tags":"psilocybin","topic_tags":"Depression,Chronic Pain,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:25:59","bibtex":null,"source_record_id":"https://openalex.org/W7139416359","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://openalex.org/W7139416359","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://openalex.org/W7139416359","source_url":"https://openalex.org/W7139416359","doi":"","pmid":"","publication_date":"2024-10-31","importer_version":"2.1.3","text_redistributed":false}},{"id":114,"title":"Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM","authors":"Beidas Zeina, Ragnhildstveit Anya, Blackman Adam, Anderson Thomas, Fewster Emily, Syed Omer A., Sobolenko Valentyne, Kanca Ismail Kaan, Son Tatiana, Farb Norman, Petranker Rotem","journal":"BJPsych Open","publication_date":"2026-05-01","publication_year":2026,"doi":"10.1192/bjo.2026.12000","pubmed_id":"42125778","openalex_id":"https://openalex.org/W7161014612","source_url":"https://doi.org/10.1192/bjo.2026.12000","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Clinical Trial","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:48","bibtex":null,"source_record_id":"PMID:42125778","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42125778","source_url":"https://doi.org/10.1192/bjo.2026.12000","doi":"10.1192/bjo.2026.12000","pmid":"42125778","publication_date":"2026-05-01","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"BJPsych Open","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}